The ASCO Nominating Committee has selected 13 distinguished members as candidates for open leadership positions within the Society. ASCO encourages all eligible members to cast their ballots to choose ...

The Retreat guides Hematology/Oncology training program leaders in discovering best practices and innovative curricula. This is a prime opportunity for networking, sharing resources, learning from ...

The American Society of Clinical Oncology (ASCO) is offering free One-Day Quality Training Program Workshops throughout the United States! This is an oncology-focused introduction to quality ...

The nomination period for the upcoming ASCO Election closed in June 2025. After reviewing the list of highly qualified candidates and completing several interviews over the summer, the Nominating ...

Conquering cancer through research, education, and promotion of the highest quality patient care. ASCO is supported by its affiliate organization, Conquer Cancer, the ASCO Foundation, which funds ...

Founded in 1964, the American Society of Clinical Oncology is the world's leading professional organization for physicians and oncology professionals caring for people with cancer.

The code will be sent via text to your WhatsApp account Important: Phone numbers added as authentication methods will only be utilized to validate login credentials and are distinct from other contact ...

An array of advertising opportunities are available before, during, and after ASCO GU. Broaden your reach and promote your brand at the premier meeting for GU cancer research and education. Formedics, ...

All Conquer Cancer research grant applications are carefully reviewed and evaluated by an independent Grants Selection Committee (Committee) using consistent criteria across all applications for each ...

In addition to gaining a global network of more than 50,000 peers, ASCO membership includes a range of benefits to enhance your career, practice, and research.

Based on funding availability, a limited number of Merit Awards will be awarded to eligible trainees and students whose research is addressed in high-quality abstracts submitted to an ASCO Meeting and ...

What did this study find? A large observational study of more than 170,000 people with diabetes and obesity found that treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist may modestly ...